22/09/2025
SELENA+ is an AI-powered retinal imaging platform designed for large-scale clinical use. It supports early detection and monitoring of major eye diseases—such as diabetic retinopathy, glaucoma, and age-related macular degeneration—as well as systemic conditions like stroke, heart disease, dementia, diabetes, and hypertension.
By detecting subtle retinal changes over time, SELENA+ enables early diagnosis, disease monitoring, and treatment evaluation—often before symptoms appear.
With over 30 patents, 20+ commercial licenses (including with leading global companies), 300+ publications, and multiple international awards, SELENA+ is clinically validated across diverse populations in Singapore, the USA, Europe, Australia, and Asia. It has been applied in more than 100,000 individuals, from healthy community cohorts to high-risk patient groups.
Contact us to know more. 017-641 3119 or email us at jim@vigourmedical.com